TrialBone marrow transplantation2020

CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.

Pooja Khandelwal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.